chr3-36993664-G-C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The ENST00000432299.6(MLH1):n.117G>C variant causes a non coding transcript exon change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
ENST00000432299.6 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000432299.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | NM_000249.4 | MANE Select | c.116+1G>C | splice_donor intron | N/A | NP_000240.1 | |||
| MLH1 | NM_001167617.3 | c.-400G>C | 5_prime_UTR | Exon 1 of 19 | NP_001161089.1 | ||||
| MLH1 | NM_001167618.3 | c.-829G>C | 5_prime_UTR | Exon 1 of 19 | NP_001161090.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MLH1 | ENST00000432299.6 | TSL:1 | n.117G>C | non_coding_transcript_exon | Exon 1 of 17 | ENSP00000416783.1 | |||
| MLH1 | ENST00000231790.8 | TSL:1 MANE Select | c.116+1G>C | splice_donor intron | N/A | ENSP00000231790.3 | |||
| MLH1 | ENST00000456676.7 | TSL:1 | c.116+1G>C | splice_donor intron | N/A | ENSP00000416687.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
Classiffication based on ACMG guidelines. This splicing variant is predicted by Human Splicing Finder to disrupt the wild-type donor site. There is another change in the nucleotide sequence reported in that position, listed in ClinVar and classified as likely pathogenic (Variation ID: 89656). Applying the ACMG criteria we can classify it as Likely Pathogenic. The patient with this mutation has 4 affected family members who died without genetic testing: Father died at 64 after rectal cancer; Aunt died at 28 after ovarian cancer; Grandmother died at 72 after uterine, rectum, and ovarian cancer; Grandmother's sister died at 39 after ovarian cancer. Interestingly this patient presented coexistence of another relevant variant, a VUS (variant of uncertain significance) in the MSH2 gene, p.P616R (heterozygous).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at